CSF synaptic biomarkers and cognitive impairment in multiple sclerosis
Lower CSF synaptic biomarker levels were found in PwMS with longer disease duration and lower brain volumes and may identify PwMS at risk of CI.
Authors
- Samir Abu‐Rumeileh (ORCID: https://orcid.org/0000-0003-0631-8506)
- Steffen Halbgebauer (ORCID: https://orcid.org/0000-0002-8711-5702)
- Lucilla Parnetti (ORCID: https://orcid.org/0000-0001-5722-3967)
- Elena Di Sabatino
- Patrick Oeckl (ORCID: https://orcid.org/0000-0002-7652-7023)
- Massimiliano Di Filippo (ORCID: https://orcid.org/0000-0002-2645-7477)
- Lorenzo Barba (ORCID: https://orcid.org/0000-0003-1328-3620)
- Markus Otto (ORCID: https://orcid.org/0000-0003-4273-4267)
- Silvia Sperandei (ORCID: https://orcid.org/0009-0006-9239-0289)
- Petra Steinacker
- Lorenzo Gaetani (ORCID: https://orcid.org/0000-0003-3967-8954)
Institutions
- Universität Ulm (DE)
- University of Perugia (IT)
- German Center for Neurodegenerative Diseases (DE)
- Martin Luther University Halle-Wittenberg (DE)
Publication Details
- Journal
- Journal of Neurology
- Published
- 2024-12-21
- DOI
- https://doi.org/10.1007/s00415-024-12851-x
- Citations
- 3
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.27
Funders
- Fondazione Italiana Sclerosi Multipla
- Bundesministerium für Bildung und Forschung
- Ministero della Salute
- Universität Ulm